logo

Last Update

This profile was last updated on 8/15/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Barbara White?

Barbara J. White

Chief Medical Officer

Corbus Pharmaceuticals Holdings Inc

HQ Phone:  (617) 963-0100

Direct Phone: (617) ***-****direct phone

Email: b***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Corbus Pharmaceuticals Holdings Inc

100 River Ridge Drive

Norwood, Massachusetts,02062

United States

Company Description

Corbus Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases. Our lead product candidate, Resunabâ„¢ ...more

Background Information

Employment History

Professor of Medicine and Vice Chair for Research, Department of Medicine

University of Maryland


Co-Director

Johns Hopkins University


Senior Vice President and Head of Research and Development

Stiefel Laboratories , Inc.


Roles

UCB S.A


Senior Director

MedImmune , Inc.


Affiliations

HOA

Board Member


American College of Rheumatology

Board Member


Food and Drug Administration

Ad Hoc Member of the Arthritis Advisory Committee


Education

University of Maryland


MD


medical degree

University of Pennsylvania School of Medicine


Web References(115 Total References)


www.sec.gov


0001625844 White Barbara C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062 0 1 0 0 Chief Medical Officer


ir.corbuspharma.com [cached]

Barbara White, MD
Barbara White, MD Chief Medical Officer Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and dermatology diseases. She also has industry experience in pre-clinical drug development, translational medicine and medical affairs. Prior to joining Corbus, Dr. White was Senior Vice President and Head of R&D at Stiefel, a GSK company. She has held roles at UCB, MedImmune and Amgen. Prior to her pharmaceutical career, Dr. White was professor of medicine and Vice Chair for Research, Department of Medicine, at the University of Maryland School of Medicine. Her research has focused on T cells and immune-mediated mechanisms of lung fibrosis in scleroderma. She also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.


ir.corbuspharma.com [cached]

Barbara White, MD
Chief Medical Officer Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and View Full Bio


ir.corbuspharma.com [cached]

Barbara White, MD, Chief Medical Officer of the Company, will present the data from the Phase 2 study of anabasum in diffuse cutaneous systemic sclerosis today, Monday, August 7, as part of the New Therapeutic Approaches and Translational Observations session.
To view Dr. White's presentation, please click here. "These new data provide robust additional evidence for on-target effects of anabasum on inflammation and fibrosis in systemic sclerosis patients and are consistent with the previously reported changes in gene-transcript data in skin biopsies from the same patients," commented Dr. White.


ir.corbuspharma.com [cached]

"With the conclusion of a successful end-of-Phase 2 meeting with FDA, we believe we have a clear path forward to advance the clinical development of anabasum to support an NDA for the treatment of systemic sclerosis," said Barbara White, M.D., Chief Medical Officer of Corbus.
"We are engaging the European Medicines Agency ("EMA") in similar discussions.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory